431 related articles for article (PubMed ID: 18393984)
1. Congenital hypofibrinogenemia associated with novel heterozygous fibrinogen Bbeta and gamma chain mutations.
Castaman G; Giacomelli SH; Duga S; Rodeghiero F
Haemophilia; 2008 May; 14(3):630-3. PubMed ID: 18393984
[No Abstract] [Full Text] [Related]
2. Three cases of abnormal fibrinogens: sumperk (Bbeta His67Leu), Unicov (Bbeta Gly414Ser), and Brno (gammaArg275His).
Kotlín R; Reicheltová Z; Sobotková A; Suttnar J; Salaj P; Pospísilová D; Smejkal P; Chrastinová L; Dyr JE
Thromb Haemost; 2008 Dec; 100(6):1199-200. PubMed ID: 19132250
[No Abstract] [Full Text] [Related]
3. A case of congenital afibrinogenemia: fibrinogen Hakata, a novel nonsense mutation of the fibrinogen gamma-chain gene.
Iida H; Ishii E; Nakahara M; Urata M; Wakiyama M; Kurihara M; Watanabe K; Kai T; Ihara K; Kinoshita S; Hamasaki N
Thromb Haemost; 2000 Jul; 84(1):49-53. PubMed ID: 10928469
[TBL] [Abstract][Full Text] [Related]
4. Clinical and biological features of 3 cases of hypofibrinogenemia associated with three different mutations (gamma Ala341Thr, Bbeta Tyr326Cys and Aalpha Asp496Asn).
Hanss M; Chevreaud C; French P; Négrier C; de Mazancourt P
Thromb Haemost; 2007 Sep; 98(3):689-91. PubMed ID: 17849064
[No Abstract] [Full Text] [Related]
5. Analysis of Iranian patients allowed the identification of the first truncating mutation in the fibrinogen Bbeta-chain gene causing afibrinogenemia.
Asselta R; Spena S; Duga S; Peyvandi F; Malcovati M; Mannucci PM; Tenchini ML
Haematologica; 2002 Aug; 87(8):855-9. PubMed ID: 12161363
[TBL] [Abstract][Full Text] [Related]
6. Functional characterisation of plasma fibrin clots in Polish carriers of fibrinogen gammaArg275His mutation (fibrinogen Zabrze).
Undas A; Pastuszczak M; Iwaniec T; Kapelak K; Neerman-Arbez M
Thromb Haemost; 2010 Aug; 104(2):415-7. PubMed ID: 20508898
[No Abstract] [Full Text] [Related]
7. A novel fibrinogen Bbeta chain frameshift mutation in a patient with severe congenital hypofibrinogenaemia.
Xu X; Wu J; Zhai Z; Zhou R; Wang X; Wang H; Ding K; Sun Z; Ni H
Thromb Haemost; 2006 Jun; 95(6):931-5. PubMed ID: 16732370
[TBL] [Abstract][Full Text] [Related]
8. Novel fibrinogen mutation (gamma 313 Ser-->Asn) associated with hypofibrinogenemia in two unrelated families.
Meyer M; Bergmann F; Brennan SO
Blood Coagul Fibrinolysis; 2006 Jan; 17(1):63-7. PubMed ID: 16607083
[TBL] [Abstract][Full Text] [Related]
9. A C-terminal amino acid substitution in the gamma-chain caused by a novel heterozygous frameshift mutation (Fibrinogen Matsumoto VII) results in hypofibrinogenaemia.
Fujihara N; Haneishi A; Yamauchi K; Terasawa F; Ito T; Ishida F; Okumura N
Thromb Haemost; 2010 Aug; 104(2):213-23. PubMed ID: 20589319
[TBL] [Abstract][Full Text] [Related]
10. Hypofibrinogenemia due to novel 316 Asp --> Tyr substitution in the fibrinogen Bbeta chain.
Brennan SO; Wyatt JM; May S; De Caigney S; George PM
Thromb Haemost; 2001 Mar; 85(3):450-3. PubMed ID: 11307813
[TBL] [Abstract][Full Text] [Related]
11. A novel fibrinogen variant--Liberec: dysfibrinogenaemia associated with gamma Tyr262Cys substitution.
Kotlín R; Sobotková A; Suttnar J; Salaj P; Walterová L; Riedel T; Reicheltová Z; Dyr JE
Eur J Haematol; 2008 Aug; 81(2):123-9. PubMed ID: 18485115
[TBL] [Abstract][Full Text] [Related]
12. Identification of Two Novel Fibrinogen Bβ Chain Mutations in Two Slovak Families with Quantitative Fibrinogen Disorders.
Simurda T; Zolkova J; Snahnicanova Z; Loderer D; Skornova I; Sokol J; Hudecek J; Stasko J; Lasabova Z; Kubisz P
Int J Mol Sci; 2017 Dec; 19(1):. PubMed ID: 29286337
[TBL] [Abstract][Full Text] [Related]
13. The β-chain mutation p.Trp433Stop impairs fibrinogen secretion: A novel nonsense mutation associated with hypofibrinogenemia.
Yan J; Wu Y; Liao L; Xiang L; Qiu Y; Lin F
Int J Lab Hematol; 2021 Dec; 43(6):1549-1556. PubMed ID: 34185392
[TBL] [Abstract][Full Text] [Related]
14. Hypodysfibrinogenemia: A novel abnormal fibrinogen associated with bleeding and thrombotic complications.
Amri Y; Kallel C; Becheur M; Dabboubi R; Elloumi M; Belaaj H; Kammoun S; Messaoud T; de Moerloose P; Toumi Nel H
Clin Chim Acta; 2016 Sep; 460():55-62. PubMed ID: 27343352
[TBL] [Abstract][Full Text] [Related]
15. Fibrinogen Poissy II (gammaN361K): a novel dysfibrinogenemia associated with defective polymerization and peptide B release.
Mathonnet F; Guillon L; Detruit H; Mazmanian GM; Dreyfus M; Alvarez JC; Giudicelli Y; de Mazancourt P
Blood Coagul Fibrinolysis; 2003 Apr; 14(3):293-8. PubMed ID: 12695754
[TBL] [Abstract][Full Text] [Related]
16. Congenital afibrinogenemia: Identification and characterization of two novel homozygous fibrinogen Aα and Bβ chain mutations in two Tunisian families.
Amri Y; Toumi Nel H; Hadj Fredj S; de Moerloose P
Thromb Res; 2016 Jul; 143():11-6. PubMed ID: 27164460
[TBL] [Abstract][Full Text] [Related]
17. Characterisation of a novel nonsense mutation in FGG (Fibrinogen Poznan) causing hypofibrinogenaemia with a mild bleeding tendency.
Zawilska K; Undas A; Fish RJ; Molendowicz-Portala L; De Moerloose P; Neerman-Arbez M
Thromb Haemost; 2010 Mar; 103(3):677-9. PubMed ID: 20135062
[No Abstract] [Full Text] [Related]
18. A nonsense mutation in FGA g.3807C-->T (p.R159X) causes afibrinogenaemia in the homozygous form.
Marchi Cappelletti R; Tersek Y; Ruiz-Sáez A; Meyer M
Acta Haematol; 2009; 121(4):216-7. PubMed ID: 19468208
[No Abstract] [Full Text] [Related]
19. Congenital hypofibrinogenemia: characterization of two missense mutations affecting fibrinogen assembly and secretion.
Platè M; Asselta R; Spena S; Spreafico M; Fagoonee S; Peyvandi F; Tenchini ML; Duga S
Blood Cells Mol Dis; 2008; 41(3):292-7. PubMed ID: 18676163
[TBL] [Abstract][Full Text] [Related]
20. Fibrinogen Saint-Germain II: hypofibrinogenemia due to heterozygous gamma N345S mutation.
de Raucourt E; de Mazancourt P; Maghzal GJ; Brennan SO; Mosesson MW
Thromb Haemost; 2005 Nov; 94(5):965-8. PubMed ID: 16363237
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
